About the Conference

Health care antitrust enforcement and litigation are changing faster than the guidance meant to govern them. The FTC and DOJ have withdrawn their longstanding safety zones, and new competitor collaboration guidance is still taking shape. Meanwhile, private litigation is expanding across drug pricing, algorithmic pricing, and provider markets. Health care organizations now face heightened exposure with fewer clear rules.

Over two afternoons, the conference brings together outside counsel, in-house legal leaders, economists, and state enforcers for practical analysis of these developments. Faculty include attorneys from the California Department of Justice and the Minnesota Attorney General's Office, alongside chief legal officers from health systems, payers, and health care services companies.

Each session is built for attorneys and compliance professionals who advise on transactions, contracting, and collaborations. These professionals need to anticipate how regulators, courts, and private plaintiffs are likely to respond. Participants can join from their home or office and put questions to faculty in real time.

What the Conference Covers

Over two afternoons, faculty will address the antitrust issues that most directly affect health care providers, payers, and their counsel, from deal risk to professional responsibility:

• Anticipate litigation exposure: Examine emerging antitrust claims against health care providers and where litigation may also present strategic opportunities.
• Reassess collaboration compliance: Evaluate how to approach competitor collaborations now that the agencies' safety zones no longer apply.
• Avoid payor contracting pitfalls: Identify antitrust risks for hospitals, health systems, and other provider organizations in negotiations with payors.
• Manage transaction risk: Address antitrust considerations from diligence through closing.
• Navigate state notification laws: Compare how state pre-transaction notification laws operate in practice, including perspectives from state enforcers.
• Evaluate the failing firm defense: Understand how acquisitions of financially distressed hospitals are analyzed and defended.
• Apply ethics obligations to AI: Consider the professional responsibility implications of using AI in legal practice.

Who Should Attend

The conference is designed for in-house counsel at hospitals, health systems, and payers; outside counsel advising on antitrust, transactions, and litigation; compliance officers; and consultants and economists who support health care antitrust matters.